Analysis showed that the frequency of SIRPα/β+memory B cells was consistently reduced in ADA+ compared to ADA− RA patients at the 1-year follow-up [t-test following removal of outliers (ROUT Q = 1%) (25)]. The gene discussed is SIRPA; the disease is rheumatoid arthritis.